The Rarest Drug on Earth
An incredibly rare isotope called Actinium-225 could revolutionize the way we treat cancer. Preliminary trials have obliterated cancer in patients given only weeks to live. There's only one problem: it's almost impossible to obtain. Today, most of our global supply comes from American radioactive waste, but it's barely enough to treat a handful of patients per year. Due to this shortage, it's been impossible to do a large-scale clinical trial. A team of researchers in Vancouver is trying to change that. At TRIUMF - the world's largest cyclotron particle accelerator - scientists are looking at a new way to make Actinium-225 using leftover particles from the accelerator. If successful, Canada could become the global supplier of a brand new, lifesaving cancer treatment.
Double Blind, began as a weekly science podcast where we provide in-depth discussion and analysis of breaking science news stories. In 2017 the project evolved into a YouTube channel which we update every few months with explainer videos on scientific or political topics.
There is an exciting new series currently in production, with a planned release in late 2018.
Combining my background in oceanography with my passion for science communication, I have served as an education and outreach officer onboard both the JOIDES Resolution and the R/V Atlantis. This work included production of live video broadcasts, short web videos, a website, and a podcast.